Trial Identifier: | D6580C00013 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
NCTID:: | NCT05236543 |
Start Date: | February 2022 |
Primary Completion Date: | August 2022 |
Study Completion Date: | August 2022 |
Condition: | Healthy Volunteers |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version |
Country | Location |
---|---|
GB | Harrow, GB, HA1 3UJ |